新闻

关于OncoC4与AcroImmune的合并声明已获得多家主流媒体的热烈关注，部分报道如下：

1. Drug Discovery World:  Immunotherapy companies OncoC4 and AcroImmune to merge
2. ApexOnco (Oncology Pipeline):  OncoC4 creates a bispecific buzz
3. Fierce Biotech:  OncoC4 founders take own science under their wing in new biotech merger
4. BioWorld Newsletter
5. BioWord Asia Newsletter
6. Oct 3 Newsletter – Labiotech
7. The top biotech deals of September 2024 – labiotech.eu